🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA warning letters to compounding pharmacies — November 2025 Page 7

FDA warning letters to compounding pharmacies — November 2025

gary_naperville Sun, Mar 15, 2026 at 7:46 PM 36 replies 1,552 viewsPage 7 of 8
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Mar 28, 2026 at 10:11 PM#31

Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Mar 28, 2026 at 11:11 PM
35 10rachel_ABQ, traveltech_sara, AttorneyGrant and 32 others
Reply Quote Save Share Report
WendyG_ATL
Member
1,023
5,678
Apr 2024
Georgia
Mar 29, 2026 at 1:27 PM#32
Dr.PulmRoch said:
If two explanations both fit, the useful question is which one predicts something the other does not.

This matches mine closely enough to be worth saying so out loud. Posting only so the count is not one.

Last edited: Mar 29, 2026 at 2:27 PM
34 9rachel_ABQ, traveltech_sara, AttorneyGrant and 31 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Mar 30, 2026 at 4:43 AM#33
Dr.PulmRoch said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Coming at Dr.PulmRoch’s question from a different direction. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Last edited: Mar 30, 2026 at 7:43 AM
33 8paul_denver, TinaHashiRN, robert_kc and 30 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
josh_phd_bmore
Member
389
1,678
Jul 2024
Baltimore, MD
Mar 30, 2026 at 7:59 PM#34

The figures, for anyone assembling their own picture. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Last edited: Mar 30, 2026 at 9:59 PM
32 7KarenAZ_mom, zoe_NC, Dr.ObesityLA and 29 others
Reply Quote Save Share Report
BrianDallas92
Member
312
1,456
Oct 2024
Dallas, TX
Mar 31, 2026 at 11:16 AM#35

One thing that is still open after Dr.PulmRoch’s answer:

What did you change at the same time, and can you separate the two now?

31 6GraceAZ_72, carl_compliance, DanielChem_CHI and 28 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register